Sikka, Arron <br/><br/>
Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  Apr 2012 
 - 1374-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.4161/cc.19798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin D1--metabolism<br/>Cyclin E--analysis<br/>Cyclin-Dependent Kinase 2--metabolism<br/>Cyclin-Dependent Kinase 4--metabolism<br/>Cyclin-Dependent Kinase 6--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p15--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p16<br/>Cyclin-Dependent Kinase Inhibitor p18--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27--metabolism<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Metformin--pharmacology<br/>Neoplasm Proteins--metabolism<br/>Protein Biosynthesis--drug effects<br/>S-Phase Kinase-Associated Proteins--metabolism<br/>Squamous Cell Carcinoma of Head and Neck<br/>beta-Transducin Repeat-Containing Proteins--metabolism<br/>rho GTP-Binding Proteins--metabolism